| Serial Number | 76272075 |
| Word Mark | ZEEBLOK |
| Filing Date | Thursday, June 14, 2001 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Thursday, October 3, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 8, 2002 |
| Goods and Services | Pharmaceutical preparation for the treatment of alcoholism and drug addiction, namely a naltrexone formulation |
| Pseudo Mark | ZEE BLOCK |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 26, 2001 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DrugAbuse Sciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
| Party Name | DrugAbuse Sciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Altos, CA 94022 |
| Event Date | Event Description |
| Thursday, February 13, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, October 22, 2002 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 2, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 8, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 19, 2001 | NOTICE OF PUBLICATION |
| Monday, October 1, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 25, 2001 | EXAMINERS AMENDMENT MAILED |
| Thursday, August 23, 2001 | NON-FINAL ACTION MAILED |
| Monday, August 20, 2001 | ASSIGNED TO EXAMINER |